We are honored that our SABCS poster, #P4-08-27: PMD-026, a First-in-Class RSK Inhibitor, Overcomes Acquired Resistance to CDK4/6 Inhibitors or Aromatase Inhibitors in HR+/HER2- Breast Cancer Preclinical Models, has won the 2024 GRASP Advocate Choice Award.

This recognition underscores the importance of collaboration between patients, clinicians, and researchers in advancing meaningful solutions for breast cancer. Thank you to GRASP for this incredible honor!

Join us on Tuesday, December 17, during the GRASP Poster Walkthroughs, where our work will be highlighted.